 Melville, New York--Newsfile Corp. - January 17, 2023 - BioRestorative Therapies NASDAQ: BRTX BioRestorative, BRTX or the Company, a clinical stage company focused on stem cell-based therapies, announced today that management will be presenting at the virtual Investor Summit. During the presentation, BioRestorative Therapies Chief Executive Officer, Lance Alstdot, will highlight the Companys regenerative medicine platform and technology. 